EP2170388
And-CD20 mótefnissamsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
3.7.2008EP published:
12.10.2016EP application number:
08781323.4
EP translation filed:
16.11.2016Grant published:
15.12.2016EPO information:
European Patent Register
Max expiry date:
2.7.2028Expiry date:
2.7.2026Next due date:
31.7.2026
Title:
ANTI-CD20 ANTIBODY FORMULATIONS
Timeline
Today
3.7.2008EP application
12.10.2016EP Publication
16.11.2016Translation submitted
15.12.2016Registration published
2.7.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BRISBANE, Charlene, E.Address:
King of Prussia, PA, US
Name:
KETKAR, Amol, SharadAddress:
King of Prussia, PA, US
Name:
LASHMAR, Ulla, ToveAddress:
Harlow, Essex CM19 5AW, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
948220 PDate:
6.7.2007Country:
US
Supplementary protection
SPC number:
SPC351
Classification
Categories:
C07K 16/00, A61K 39/395, C07K 16/28, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 26.6.2017
Expires: 2.7.2018
Payer: Árnason Faktor
Number: 11
Paid: 27.6.2018
Expires: 2.7.2019
Payer: Árnason Faktor
Number: 12
Paid: 25.6.2019
Expires: 2.7.2020
Payer: Árnason Faktor
Number: 13
Paid: 25.6.2020
Expires: 2.7.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 24.6.2021
Expires: 2.7.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 29.6.2022
Expires: 2.7.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 28.6.2023
Expires: 2.7.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 24.6.2024
Expires: 2.7.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 4.7.2025
Expires: 2.7.2026
Payer: Árnason Faktor ehf.